about
Opioid-induced bowel dysfunction: prevalence, pathophysiology and burdenPrevalence of opioid dispensings and concurrent gastrointestinal medications in QuebecEffects of nociceptin/orphanin FQ on rats with cathartic colonEfficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipationPrevalence of narcotic bowel syndrome in opioid abusers in iran.Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxoneThe relationship between opioid and sugar intake: review of evidence and clinical applications.Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study.Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesicsThe narcotic bowel syndrome: clinical features, pathophysiology, and managementAssociations between medication use and functional gastrointestinal disorders: a population-based study.Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.International perspectives on pain and palliative care.Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids.Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulation.Opioid-induced bowel dysfunction.Pharmacologic treatment of opioid-induced constipation.
P2860
Q28209970-79457EDB-CAE3-4F78-B622-AF833D75CB42Q33562118-C2867E81-F3C8-490C-98CB-C6245CADEE87Q33787537-1473C62B-1881-4684-A037-12C421E9660DQ34146166-A999F382-FF21-4D85-A629-B33E610C610FQ34401446-B1F338F9-46B7-4524-BCE5-7CB087AD6051Q34552212-3FC81906-22D4-40B9-8E3D-C03C88B7093AQ34798408-3AC99B6B-2B38-4FF3-B4A1-845F62795225Q35029992-9024237A-E9C6-4300-BA0E-D2F0B8DAAA75Q35532548-9D4E289B-56AB-43F8-8697-5E13E2040700Q35893940-AE295617-28CB-4860-8CAD-E98334E880CDQ36136622-B2A531DD-441B-4A00-BE35-EDDFDFA959BDQ36780776-8F475A56-498E-4797-838B-BA80B8811719Q36823204-96FBD2E4-334F-4D38-8CAA-F0423D73EC54Q37417620-D4486AA7-46A7-44ED-BB10-7535D83BC131Q37611847-1DD1F1CE-70AB-4EFB-9275-312D169C086CQ38511326-5D41C6AA-1BF8-476E-B839-84F81F5CB046Q39051851-F2A2C2F0-D9F6-42EF-A6DF-7556B20928F3Q39234260-4EE8414B-0EAF-43C9-8F6D-CE3021F72038Q42323281-26625CBC-319B-404F-B0D9-75D1A5814A97Q43442255-2A00B2E7-26E0-4E12-AE25-9A2DB157B062
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Opioid-induced gastrointestinal dysfunction.
@ast
Opioid-induced gastrointestinal dysfunction.
@en
type
label
Opioid-induced gastrointestinal dysfunction.
@ast
Opioid-induced gastrointestinal dysfunction.
@en
prefLabel
Opioid-induced gastrointestinal dysfunction.
@ast
Opioid-induced gastrointestinal dysfunction.
@en
P356
P1433
P1476
Opioid-induced gastrointestinal dysfunction.
@en
P2093
Chun-Su Yuan
Sangeeta R Mehendale
P2860
P304
P356
10.1159/000090314
P577
2006-01-01T00:00:00Z